AU2003244885A1 - Oral delivery of biological active agents in a nanoemulsion formulation to the human body - Google Patents

Oral delivery of biological active agents in a nanoemulsion formulation to the human body

Info

Publication number
AU2003244885A1
AU2003244885A1 AU2003244885A AU2003244885A AU2003244885A1 AU 2003244885 A1 AU2003244885 A1 AU 2003244885A1 AU 2003244885 A AU2003244885 A AU 2003244885A AU 2003244885 A AU2003244885 A AU 2003244885A AU 2003244885 A1 AU2003244885 A1 AU 2003244885A1
Authority
AU
Australia
Prior art keywords
human body
active agents
oral delivery
biological active
nanoemulsion formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003244885A
Inventor
Endre D. Radics
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003244885A1 publication Critical patent/AU2003244885A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003244885A 2002-06-19 2003-06-18 Oral delivery of biological active agents in a nanoemulsion formulation to the human body Abandoned AU2003244885A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0202032A HUP0202032A2 (en) 2002-06-19 2002-06-19 Bioactive materials in nanoemulsion form for intake to human organ throogh the mucous membrane of mouth cavity by spray of mechanic pump
HUP0202032 2002-06-19
PCT/HU2003/000049 WO2004000274A1 (en) 2002-06-19 2003-06-18 Oral delivery of biological active agents in a nanoemulsion formulation to the human body

Publications (1)

Publication Number Publication Date
AU2003244885A1 true AU2003244885A1 (en) 2004-01-06

Family

ID=89980533

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003244885A Abandoned AU2003244885A1 (en) 2002-06-19 2003-06-18 Oral delivery of biological active agents in a nanoemulsion formulation to the human body

Country Status (4)

Country Link
AU (1) AU2003244885A1 (en)
GB (1) GB0500594D0 (en)
HU (1) HUP0202032A2 (en)
WO (1) WO2004000274A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3988168B1 (en) * 2006-04-07 2007-10-10 伸司 嶋田 Composition having brain cell activity effect by ginkgo biloba leaf nanoparticle
JP5459939B2 (en) * 2006-06-09 2014-04-02 富士フイルム株式会社 Carotenoid-containing emulsion composition, method for producing the same, food containing the same, and cosmetics
CN101759727B (en) * 2009-09-30 2013-03-27 钱娟 Nano-scale pine bark extract and preparation method thereof
PL2512648T3 (en) * 2009-12-15 2018-07-31 Emultec S.R.L. Nanoemulsion, method for its preparation and use
US9468626B2 (en) 2014-03-13 2016-10-18 Chiesi Farmaceutici S.P.A. Melatonin-based formulations for parenteral administration

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4525341A (en) * 1984-04-09 1985-06-25 Mayor Pharmaceutical Laboratories, Inc. Method of administering vitamins
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5891465A (en) * 1996-05-14 1999-04-06 Biozone Laboratories, Inc. Delivery of biologically active material in a liposomal formulation for administration into the mouth
FR2788007B1 (en) * 1999-01-05 2001-02-09 Oreal NANOEMULSION BASED ON BLOCK COPOLYMERS OF ETHYLENE OXIDE AND PROPYLENE OXIDE, AND ITS USES IN THE COSMETIC, DERMATOLOGICAL AND / OR OPHTHALMOLOGICAL FIELDS
FR2804016B1 (en) * 2000-01-21 2006-07-28 Oreal NANEMULSION CONTAINING AMPHIPHILIC LIPIDS AND PEG ESTER AND USES THEREOF
FR2804014B1 (en) * 2000-01-21 2002-10-18 Oreal NANOEMULSION BASED ON AMPHIPHILIC LIPIDS AND CATIONIC POLYMERS AND USES
JP4549625B2 (en) * 2002-01-05 2010-09-22 株式會社アモーレパシフィック Finely emulsified particles containing ginseng saponin metabolites as active ingredients, a method for producing the same, and a cosmetic composition for preventing skin aging containing the same

Also Published As

Publication number Publication date
WO2004000274A1 (en) 2003-12-31
HUP0202032A2 (en) 2004-10-28
HU0202032D0 (en) 2002-08-28
GB0500594D0 (en) 2005-02-16

Similar Documents

Publication Publication Date Title
AU2003295614A1 (en) Delivery of pharmaceutical agents via the human insulin receptor
AU2003264282A1 (en) Phenethanolamine derivatives and their use in the treatment of respiratory diseases
DE60237199D1 (en) IMMEDIATE DELIVERY TO THE BODY OF A PATIENT
AU2003229084A1 (en) Methods and formulations for the delivery of pharmacologically active agents
HK1066466A1 (en) Pharmaceutical formulations of antineoplastic agents in particular temozolomide processes of making and using the same
AU2003210321A1 (en) Use of sugar esters in cosmetic and/or pharmaceutical preparations
AU1200501A (en) Drug delivery catheters that attach to tissue and methods for their use
AU2003280918A1 (en) Rabbit skin comprising biological active substance and its use
GB0500594D0 (en) Oral delivery of biological active agents in a nanoemulsion formulation to the human body
AU2003248153A1 (en) Honey-based skin care preparation
EP1491210A4 (en) Therapeutic drug using antibody-presenting hollow protein nanoparticles and hollow protein nanoparticles
AU2002224471A1 (en) In vivo stimulation of angiogenic activity
AU2002352566A1 (en) Use of corrinoids in the treatment of skin diseases
AU2002253785A1 (en) Catheter and implants for the delivery of therapeutic agents to tissues
EP1583545A4 (en) Pharmaceutical composition for improved administration of hiv gp41-derived peptides, and its use in therapy
AU2003244455A1 (en) Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
AU2003234548A1 (en) Solubilized formulations containing nylon suitable for personal care products
PL1663101T3 (en) Administration form and kit for the oral administration of active substances, vitamins and/or nutrients and use thereof
AU2003235887A1 (en) Bislactone derivative and use thereof in medicinal composition
AU2003286206A1 (en) Use of a pear must extract as active principle in a cosmetic and/or pharmaceutical composition
AU2003275947A1 (en) Pharmaceutical composition comprising a tissue factor antagonist and a blood glucose regulator
AU2003257624A1 (en) Medical instrument to be implanted in the body
AU2003240446A1 (en) Use of mob-5 in pain
AU2003244498A1 (en) Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
AU2003229656A1 (en) A pharmaceutical formulation for endonasal administration and its use in the treatment of rhinitic symptoms

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase